A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS ONE

Topics

Medicine

Immunology

Pathology

Internal Medicine

Gastroenterology

Show all topics

DOI

10.1371/journal.pone.0063818

License

CC-BY

Other Formats

PDF